The Medical Miracle: More Questions

AIDS Reader

Volumn 15, Issue 12, 2005, Pages 657-658

  Laurence, Jeffrey ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b American Foundation for AIDS Research   (United States)

Author keywords

HAART; HIV dementia; HIV AIDS; Immune reactivity; Viral fitness

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV; HIV INFECTIONS; HUMANS;

EID: 33644801799     PISSN: 10530894     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (13)

1. Laurence J. A medical miracle, but for how long? AIDS Reader. 2005;15:502,505.
2. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366:378-384.
3. Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19:1407-1414.
4. Lawn SD, Bekker LG, Wood R. How effectively does HAART restore immune responses to Mycobacterium tuberculosis! Implications for tuberculosis control. AIDS. 2005;19:1113-1124.
5. + T lymphocyte decline. Proc Natl Acad Sci U S A. 2005;102:15647-15652.
6. Scans show how HIV attacks brain. BBC News. October 11,2005.
7. Neuenburg JK, Furlan S, Bacchetti P, et al. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy. AIDS. 2005;19:1351-1359.
8. Popovic M, Tenner-Racz K, Pelser C, et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 2005;102:14807-14812.
9. Veazey RS, Lackner AA. HIV swiftly guts the immune system. Nat Med. 2005; 11:469-470.
10. + T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol. 2004;173:2184-2189.
11. Arien KK, Troyer RM, Gali Y, et al. Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time. AIDS. 2005;19:1555-1564.
12. Vlahov D. HIV and injection drug use: adherence, resistance and death. Presented at Weill Medical College of Cornell University Department of Public Health Grand Rounds; October 18, 2005; New York.
13. Duarte E, Clarke D, Moya A, et al. Rapid fitness losses in mammalian RNA virus clones due to Muller's ratchet. Proc Natl Acad Sci U S A. 1992;89:6015-6019.